Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

29
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
29
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Mild autonomic cortisol secretion: comorbidities and surgical treatment outcomes].

Medicina·2025
Same author

Primary empty sella

Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)·2025
Same author

Double pituitary adenoma associated with acromegaly and hyperprolactinemia: a case report.

Archives of endocrinology and metabolism·2025
Same author

[Sarcopenia: new cut-off value of handgrip in postmenopausal Argentine women].

Medicina·2024
Same author

[Pituitary metastases: a diagnostic and therapeutic challenge].

Medicina·2024
Same author

[Primary hypophysitis: diagnosis and treatment multicenter study].

Medicina·2023
Same journal

Association of MBL2 Polymorphisms with HAM/TSP in HTLV-1 Infection: A Case-Control Study Approach.

Archives of medical research·2026
Same journal

Financial Costs of Tobacco-Attributable Temporary Sick Leave in Social Security Systems: The Case of Mexico, 2010-2022.

Archives of medical research·2026
Same journal

Access to Medicines for Rare Diseases in Brazil.

Archives of medical research·2026
Same journal

Perceptions, Behaviors, and Barriers among Adolescents Living with Obesity, Caregivers, and Healthcare Professionals in Mexico: ACTION Teens Study.

Archives of medical research·2026
Same journal

Clinical and Genomic Characteristics of Mexican Patients with Early Onset Gastric Adenocarcinoma.

Archives of medical research·2026
Same journal

Polymeric Immunoglobulin Receptor-Lateral Flow Immunochromatographic Strip for Cholangiocarcinoma Screening.

Archives of medical research·2026
See all related articles

Related Experiment Video

Updated: Jul 10, 2025

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

359

Acromegaly and Cancer: An Update.

Karina Danilowicz1, Soledad Sosa1

  • 1Division of Endocrinology, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, Buenos Aires, Argentina.

Archives of Medical Research
|November 25, 2023
PubMed
Summary
This summary is machine-generated.

Acromegaly, a rare disease, is linked to tumors and mortality. Disease control and comorbidity management improve survival, while personalized screening may aid early tumor detection.

Keywords:
AcromegalyBreastCancerColonMortalityProstateThyroid

More Related Videos

Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation
07:00

Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation

Published on: August 23, 2018

6.2K
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.9K

Related Experiment Videos

Last Updated: Jul 10, 2025

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

359
Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation
07:00

Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation

Published on: August 23, 2018

6.2K
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

18.9K

Area of Science:

  • Endocrinology
  • Oncology
  • Epidemiology

Background:

  • Acromegaly is a rare, chronic condition often diagnosed late.
  • Associated comorbidities and long-term growth factor exposure may increase cancer risk.
  • The link between acromegaly and cancer incidence/mortality is debated due to data limitations.

Purpose of the Study:

  • To review current knowledge on acromegaly, cancer incidence, and mortality.
  • To discuss factors influencing mortality in acromegaly patients.
  • To evaluate the role of endocrine disease surveillance in tumor detection.

Main Methods:

  • Literature review synthesizing epidemiological data and clinical findings.
  • Analysis of cancer incidence in acromegaly patients.
  • Identification of mortality predictors in acromegaly.

Main Results:

  • Cancer association with acromegaly remains controversial.
  • Disease control and comorbidity management significantly improve mortality rates.
  • Older age, elevated GH/IGF-1, malignancy, and radiotherapy are mortality predictors.

Conclusions:

  • Improved survival observed with acromegaly management.
  • Rigorous surveillance may enhance tumor detection.
  • Personalized screening strategies are recommended for acromegaly patients.